Dendritic cell subsets require cis-activation for cytotoxic CD8 T-cell induction

Nature Communications

Volumn 5, Issue , 2014, Pages

  Desch, A Nicole ^a   Gibbings, Sophie L ^b   Clambey, Eric T ^c   Janssen, William J ^b   Slansky, Jill E ^a   Kedl, Ross M ^a   Henson, Peter M ^a,b   Jakubzick, Claudia ^a,b  

^a Integrated Department of Immunology   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c Department of Anesthesiology UC Denver Anschutz Campus ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYINOSINIC POLYCYTIDYLIC ACID; RESIQUIMOD; TOLL LIKE RECEPTOR 3; ALPHA E INTEGRINS; ALPHA INTEGRIN; CD11B ANTIGEN; IMIDAZOLE DERIVATIVE; INTERLEUKIN 27; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; TLR3 PROTEIN, MOUSE; TLR7 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 7;

GENE EXPRESSION; GENETIC MARKER; MOLECULAR ANALYSIS; PATHOGEN; TOXICITY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD103+ DENDRITIC CELL; CD11B+ DENDRITIC CELL; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNOCYTOTOXICITY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; DRUG EFFECTS; FEMALE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD11B; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FEMALE; IMIDAZOLES; INTEGRIN ALPHA CHAINS; INTERLEUKIN-27; LUNG; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLY I-C; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 7;

EID: 84907302142     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5674     Document Type: Article

References (56)

1. Dudziak, D. et al. Differential antigen processing by dendritic cell subsets in vivo. Science 315, 107-111 (2007). (Pubitemid 46196991)
2. Reis, E. S. C. 2011 ESCI Award for Excellence in Basic/Translational Research: innate regulation of adaptive immunity by dendritic cells. Eur. J. Clin. Invest. 41, 907-916 (2011).
3. Plantinga, M., Hammad, H. & Lambrecht, B. N. Origin and functional specializations of DC subsets in the lung. Eur. J. Immunol. 40, 2112-2118 (2010).
4. Kim, T. S. & Braciale, T. J. Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS ONE 4, e4204 (2009).
5. Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097-1100 (2008).
6. del Rio, M. L., Rodriguez-Barbosa, J. I., Kremmer, E. & Forster, R. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J. Immunol. 178, 6861-6866 (2007). (Pubitemid 46847411)
7. Desch, A. N. et al. CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J. Exp. Med. 208, 1789-1797 (2011).
8. Longhi, M. P. et al. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206, 1589-1602 (2009).
9. Le Bon, A. et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4, 1009-1015 (2003). (Pubitemid 37265922)
10. Pilz, A. et al. Dendritic cells require STAT-1 phosphorylated at its transactivating domain for the induction of peptide-specific CTL. J. Immunol. 183, 2286-2293 (2009).
11. Fuertes, M. B. et al. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. J. Exp. Med. 208, 2005-2016 (2011).
12. Diamond, M. S. et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J. Exp. Med. 208, 1989-2003 (2011).
13. Sporri, R. & Reis, e Sousa, C Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 6, 163-170 (2005). (Pubitemid 40268197)
14. Kratky, W., Reis, e Sousa, C., Oxenius, A. & Sporri, R. Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination. Proc. Natl Acad. Sci. USA 108, 17414-17419 (2011).
15. Kurts, C., Robinson, B. W. & Knolle, P. A. Cross-priming in health and disease. Nat. Rev. Immunol. 10, 403-414 (2010).
16. Joffre, O. P., Segura, E., Savina, A. & Amigorena, S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12, 557-569 (2012).
17. Helft, J. et al. Cross-presenting CD103+ dendritic cells are protected from influenza virus infection. J. Clin. Invest. 122, 4037-4047 (2012).
18. Contreras, V. et al. Existence of CD8alpha-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species. J. Immunol. 185, 3313-3325 (2010).
19. Schulz, O., Pennington, D. J., Hodivala-Dilke, K., Febbraio, M. & Reis, e Sousa, C CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells. J. Immunol. 168, 6057-6065 (2002). (Pubitemid 34620020)
20. Bedoui, S. et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat. Immunol. 10, 488-495 (2009).
21. Edelson, B. T. et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J. Exp. Med. 207, 823-836 (2010).
22. Beauchamp, N. M., Busick, R. Y. & Alexander-Miller, M. A. Functional divergence among CD103+ dendritic cell subpopulations following pulmonary poxvirus infection. J. Virol. 84, 10191-10199 (2010).
23. Ho, A. W. et al. Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells. J. Immunol. 187, 6011-6021 (2011).
24. Sung, S. S. et al. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 176, 2161-2172 (2006).
25. Plantinga, M. et al. Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 38, 322-335 (2013).
26. Schlitzer, A. et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38, 970-983 (2013).
27. Jakubzick, C., Helft, J., Kaplan, T. J. & Randolph, G. J. Optimization of methods to study pulmonary dendritic cell migration reveals distinct capacities of DC subsets to acquire soluble versus particulate antigen. J. Immunol. Methods 337, 121-131 (2008).
28. Daley, J. M., Thomay, A. A., Connolly, M. D., Reichner, J. S. & Albina, J. E. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83, 64-70 (2008).
29. de Heer, H. J. et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200, 89-98 (2004). (Pubitemid 38924731)
30. Tussiwand, R. et al. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 490, 502-507 (2012).
31. Hoffmann, P. R. et al. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J. Cell. Biol. 155, 649-659 (2001). (Pubitemid 34289322)
32. Schulz, O. et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433, 887-892 (2005). (Pubitemid 40314900)
33. Kato, H. et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23, 19-28 (2005). (Pubitemid 41019654)
34. Pooley, J. L., Heath, W. R. & Shortman, K. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but crosspresented to CD8 T cells by CD8+ dendritic cells. J. Immunol. 166, 5327-5330 (2001). (Pubitemid 32374150)
35. den Haan, J. M., Lehar, S. M. & Bevan, M. J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192, 1685-1696 (2000).
36. Lin, M. L. et al. Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset. Proc. Natl Acad. Sci. USA 105, 3029-3034 (2008).
37. Reis, e Sousa, C. Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476-483 (2006).
38. Erwig, L. P. & Henson, P. M. Clearance of apoptotic cells by phagocytes. Cell Death Differ. 15, 243-250 (2008).
39. GeurtsvanKessel, C. H. et al. Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. J. Exp. Med. 205, 1621-1634 (2008).
40. Hao, X., Kim, T. S. & Braciale, T. J. Differential response of respiratory dendritic cell subsets to influenza virus infection. J. Virol. 82, 4908-4919 (2008). (Pubitemid 351657052)
41. Moltedo, B., Li, W., Yount, J. S. & Moran, T. M. Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection. PLoS Pathog. 7, e1002345 (2011).
42. Ballesteros-Tato, A., Leon, B., Lund, F. E. & Randall, T. D. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat. Immunol. 11, 216-224 (2010).
43. Gitlin, L. et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl Acad. Sci. USA 103, 8459-8464 (2006). (Pubitemid 43838477)
44. Lund, J. M. et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl Acad. Sci. USA 101, 5598-5603 (2004). (Pubitemid 38481202)
45. Palucka, K. & Banchereau, J. Dendritic-cell-based therapeutic cancer vaccines. Immunity 39, 38-48 (2013).
46. Bachem, A. et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J. Exp. Med. 207, 1273-1281 (2010).
47. Jongbloed, S. L. et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med. 207, 1247-1260 (2010).
48. Poulin, L. F. et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J. Exp. Med. 207, 1261-1271 (2010).
49. Demedts, I. K., Brusselle, G. G., Vermaelen, K. Y. & Pauwels, R. A. Identification and characterization of human pulmonary dendritic cellsAm. J. Respir. Cell Mol. Biol. 32, 177-184 (2005). (Pubitemid 40387643)
50. Haniffa, M. et al. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 37, 60-73 (2012).
51. Segura, E. et al. Characterization of resident and migratory dendritic cells in human lymph nodes. J. Exp. Med. 209, 653-660 (2012).
52. Klechevsky, E. et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29, 497-510 (2008).
53. Yu, C. I. et al. Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-beta. Immunity 38, 818-830 (2013).
54. Mittag, D. et al. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. J. Immunol. 186, 6207-6217 (2011).
55. Jakubzick, C. & Randolph, G. J. Methods to study pulmonary dendritic cell migration. Methods Mol. Biol. 595, 371-382 (2010).
56. Heng, T. S. & Painter, M. W. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 9, 1091-1094 (2008).